Works matching AU Wirsching, Hans-Georg

Results: 32

Socioeconomic burden and quality of life in meningioma patients.

Published in:

2020

By:

Wirsching, Hans-Georg;
Morel, Corinne;
Roth, Patrick;
Weller, Michael

Publication type:

journal article

Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery.

Published in:

Acta Neuropathologica Communications, 2017, v. 5, p. 1, doi. 10.1186/s40478-017-0443-7

By:

Cimino, Patrick J.;
Zager, Michael;
McFerrin, Lisa;
Wirsching, Hans-Georg;
Bolouri, Hamid;
Hentschel, Bettina;
von Deimling, Andreas;
Jones, David;
Reifenberger, Guido;
Weller, Michael;
Holland, Eric C.

Publication type:

Article

Targeted Therapies and Immune Checkpoint Inhibitors in Primary CNS Lymphoma.

Published in:

Cancers, 2021, v. 13, n. 12, p. 3073, doi. 10.3390/cancers13123073

By:

Wirsching, Hans-Georg;
Weller, Michael;
Balabanov, Stefan;
Roth, Patrick

Publication type:

Article

The Role of Molecular Diagnostics in the Management of Patients with Gliomas.

Published in:

2016

By:

Wirsching, Hans-Georg;
Weller, Michael

Publication type:

journal article

Spatial immune profiling of glioblastoma identifies an inflammatory, perivascular phenotype associated with longer survival.

Published in:

Acta Neuropathologica, 2023, v. 146, n. 4, p. 647, doi. 10.1007/s00401-023-02617-6

By:

Wirsching, Hans-Georg;
Felsberg, Jörg;
Prummer, Michael;
Moisoiu, Vlad;
Lourman, Roxanne;
Hertler, Caroline;
Antonios, Michelle;
Cimino, Patrick J.;
Roth, Patrick;
Gorlia, Thierry;
Prins, Robert M.;
Cloughesy, Timothy;
Wen, Patrick Y.;
Holland, Eric C.;
Reifenberger, Guido;
Weller, Michael

Publication type:

Article

A T-cell antigen atlas for meningioma: novel options for immunotherapy.

Published in:

Acta Neuropathologica, 2023, v. 146, n. 2, p. 173, doi. 10.1007/s00401-023-02605-w

By:

Medici, Gioele;
Freudenmann, Lena K.;
Velz, Julia;
Wang, Sophie Shih-Yüng;
Kapolou, Konstantina;
Paramasivam, Nagarajan;
Mühlenbruch, Lena;
Kowalewski, Daniel J.;
Vasella, Flavio;
Bilich, Tatjana;
Frey, Beat M.;
Dubbelaar, Marissa L.;
Patterson, Angelica Brooke;
Zeitlberger, Anna Maria;
Silginer, Manuela;
Roth, Patrick;
Weiss, Tobias;
Wirsching, Hans-Georg;
Krayenbühl, Niklaus;
Bozinov, Oliver

Publication type:

Article

CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas.

Published in:

Acta Neuropathologica, 2020, v. 140, n. 3, p. 409, doi. 10.1007/s00401-020-02188-w

By:

Sievers, Philipp;
Hielscher, Thomas;
Schrimpf, Daniel;
Stichel, Damian;
Reuss, David E.;
Berghoff, Anna S.;
Neidert, Marian C.;
Wirsching, Hans-Georg;
Mawrin, Christian;
Ketter, Ralf;
Paulus, Werner;
Reifenberger, Guido;
Lamszus, Katrin;
Westphal, Manfred;
Etminan, Nima;
Ratliff, Miriam;
Herold-Mende, Christel;
Pfister, Stefan M.;
Jones, David T. W.;
Weller, Michael

Publication type:

Article

Mutational patterns and regulatory networks in epigenetic subgroups of meningioma.

Published in:

Acta Neuropathologica, 2019, v. 138, n. 2, p. 295, doi. 10.1007/s00401-019-02008-w

By:

Paramasivam, Nagarajan;
Hübschmann, Daniel;
Toprak, Umut H;
Ishaque, Naveed;
Neidert, Marian;
Schrimpf, Daniel;
Stichel, Damian;
Reuss, David;
Sievers, Philipp;
Reinhardt, Annekathrin;
Wefers, Annika K.;
Jones, David T. W.;
Gu, Zuguang;
Werner, Johannes;
Uhrig, Sebastian;
Wirsching, Hans-Georg;
Schick, Matthias;
Bewerunge-Hudler, Melanie;
Beck, Katja;
Brehmer, Stephanie

Publication type:

Article

Chordoid meningiomas can be sub-stratified into prognostically distinct DNA methylation classes and are enriched for heterozygous deletions of chromosomal arm 2p.

Published in:

Acta Neuropathologica, 2018, v. 136, n. 6, p. 975, doi. 10.1007/s00401-018-1924-x

By:

Sievers, Philipp;
Stichel, Damian;
Hielscher, Thomas;
Schrimpf, Daniel;
Reinhardt, Annekathrin;
Wefers, Annika K.;
Reuss, David;
Jones, David T. W.;
Bewerunge-Hudler, Melanie;
Hartmann, Christian;
Baumgarten, Peter;
Wirsching, Hans-Georg;
Winther-Kristensen, Bjarne;
Brokinkel, Benjamin;
Ketter, Ralf;
Idoate Gastearena, Miguel Angel;
Lamszus, Katrin;
Seiz-Rosenhagen, Marcel;
Mawrin, Christian;
Harter, Patrick N.

Publication type:

Article

Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence.

Published in:

Acta Neuropathologica, 2018, v. 135, n. 6, p. 955, doi. 10.1007/s00401-018-1844-9

By:

Katz, Leah M.;
Hielscher, Thomas;
Liechty, Benjamin;
Silverman, Joshua;
Zagzag, David;
Sen, Rajeev;
Wu, Peter;
Golfinos, John G.;
Reuss, David;
Neidert, Marian Christoph;
Wirsching, Hans-Georg;
Baumgarten, Peter;
Herold-Mende, Christel;
Wick, Wolfgang;
Harter, Patrick N.;
Weller, Michael;
von Deimling, Andreas;
Snuderl, Matija;
Sen, Chandra;
Sahm, Felix

Publication type:

Article

Improved seizure control in patients with recurrent glioblastoma treated with bevacizumab.

Published in:

Neuro-Oncology, 2022, v. 24, n. 11, p. 2001, doi. 10.1093/neuonc/noac172

By:

Hertler, Caroline;
Seystahl, Katharina;
Rhun, Emilie Le;
Wirsching, Hans-Georg;
Roth, Patrick;
Weller, Michael;
Gramatzki, Dorothee

Publication type:

Article

Increase in contrast-enhancing volume of irradiated meningiomas reflects tumor progression and not pseudoprogression.

Published in:

Neuro-Oncology, 2021, v. 23, n. 9, p. 1612, doi. 10.1093/neuonc/noab119

By:

Wirsching, Hans-Georg;
Steiner, Lea;
Becker, Denise;
Regli, Luca;
Andratschke, Nicolaus;
Kulcsar, Zsolt;
Roth, Patrick;
Weller, Michael

Publication type:

Article

Anti–PD-L1 antibody direct activation of macrophages contributes to a radiation-induced abscopal response in glioblastoma.

Published in:

Neuro-Oncology, 2020, v. 22, n. 5, p. 639, doi. 10.1093/neuonc/noz226

By:

Ene, Chibawanye I;
Kreuser, Shannon A;
Jung, Miyeon;
Zhang, Huajia;
Arora, Sonali;
Moyes, Kara White;
Szulzewsky, Frank;
Barber, Jason;
Cimino, Patrick J;
Wirsching, Hans-Georg;
Patel, Anoop;
Kong, Paul;
Woodiwiss, Timothy R;
Durfy, Sharon J;
Houghton, A McGarry;
Pierce, Robert H;
Parney, Ian F;
Crane, Courtney A;
Holland, Eric C

Publication type:

Article

Cooperation of oncolytic virotherapy with VEGF-neutralizing antibody treatment in IDH wildtype glioblastoma depends on MMP9.

Published in:

Neuro-Oncology, 2019, v. 21, n. 12, p. 1607, doi. 10.1093/neuonc/noz145

By:

Wirsching, Hans-Georg;
Arora, Sonali;
Zhang, Huajia;
Szulzewsky, Frank;
Cimino, Patrick J;
Quéva, Christophe;
Houghton, A McGarry;
Glorioso, Joseph C;
Weller, Michael;
Holland, Eric C

Publication type:

Article

PATH-51. DNA COPY NUMBER PROFILING ACROSS GLIOBLASTOMA POPULATIONS HAS IMPLICATIONS FOR CLINICAL TRIAL DESIGN.

Published in:

Neuro-Oncology, 2018, v. 20, p. vi169, doi. 10.1093/neuonc/noy148.705

By:

Cimino, Patrick;
McFerrin, Lisa;
Wirsching, Hans-Georg;
Arora, Sonali;
Bolouri, Hamid;
Rabadan, Raul;
Weller, Michael;
Holland, Eric

Publication type:

Article

Copy number profiling across glioblastoma populations has implications for clinical trial design.

Published in:

Neuro-Oncology, 2018, v. 20, n. 10, p. 1368, doi. 10.1093/neuonc/noy108

By:

Cimino, Patrick J;
McFerrin, Lisa;
Wirsching, Hans-Georg;
Arora, Sonali;
Bolouri, Hamid;
Rabadan, Raul;
Weller, Michael;
Holland, Eric C

Publication type:

Article

Predicting outcome of epilepsy after meningioma resection.

Published in:

Neuro-Oncology, 2016, v. 18, n. 7, p. 1002, doi. 10.1093/neuonc/nov303

By:

Wirsching, Hans-Georg;
Morel, Corinne;
Gmür, Corinne;
Christoph Neidert, Marian;
Richard Baumann, Christian;
Valavanis, Antonios;
Jane Rushing, Elisabeth;
Krayenbühl, Niklaus;
Weller, Michael

Publication type:

Article

Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma--results from the DIRECTOR trial.

Published in:

Neuro-Oncology, 2016, v. 18, n. 4, p. 549, doi. 10.1093/neuonc/nov326

By:

Suchorska, Bogdana;
Weller, Michael;
Tabatabai, Ghazaleh;
Senft, Christian;
Hau, Peter;
Sabel, Michael C.;
Herrlinger, Ulrich;
Ketter, Ralf;
Schlegel, Uwe;
Marosi, Christine;
Reifenberger, Guido;
Wick, Wolfgang;
Tonn, Jörg C.;
Wirsching, Hans-Georg

Publication type:

Article

INHIBITING INVASION AND STEMNESS IN GLIOBLASTOMA BY THYMOSIN BETA 4 GENE SILENCING: A POTENTIAL THERAPEUTIC TARGET?

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_3, p. iii21, doi. 10.1093/neuonc/nou206.79

By:

Tabatabai, Ghazaleh;
Wirsching, Hans-Georg;
Krishnan, Shanmugarajan;
Florea, Ana-Maria;
Frei, Karl;
Krayenbühl, Niklaus;
Hasenbach, Kathy;
Reifenberger, Guido;
Weller, Michael

Publication type:

Article

Thymosin β 4 gene silencing decreases stemness and invasiveness in glioblastoma.

Published in:

2014

By:

Wirsching, Hans-Georg;
Krishnan, Shanmugarajan;
Florea, Ana-Maria;
Frei, Karl;
Krayenbühl, Niklaus;
Hasenbach, Kathy;
Reifenberger, Guido;
Weller, Michael;
Tabatabai, Ghazaleh

Publication type:

journal article

Thymosin beta 4 gene silencing decreases stemness and invasiveness in glioblastoma.

Published in:

Brain: A Journal of Neurology, 2014, v. 137, n. 2, p. 433, doi. 10.1093/brain/awt333

By:

Wirsching, Hans-Georg;
Krishnan, Shanmugarajan;
Florea, Ana-Maria;
Frei, Karl;
Krayenbühl, Niklaus;
Hasenbach, Kathy;
Reifenberger, Guido;
Weller, Michael;
Tabatabai, Ghazaleh

Publication type:

Article

Post-operative cardiovascular complications and time to recurrence in meningioma patients treated with versus without pre-operative embolization: a retrospective cohort study of 741 patients.

Published in:

Journal of Neuro-Oncology, 2018, v. 140, n. 3, p. 659, doi. 10.1007/s11060-018-2996-0

By:

Wirsching, Hans-Georg;
Richter, Johannes Konstantin;
Sahm, Felix;
Morel, Corinne;
Krayenbuehl, Niklaus;
Rushing, Elisabeth Jane;
von Deimling, Andreas;
Valavanis, Antonios;
Weller, Michael

Publication type:

Article

A prognostic model for tumor recurrence and progression after meningioma surgery: preselection for further molecular work-up.

Published in:

Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1279933

By:

Padevit, Luis;
Vasella, Flavio;
Friedman, Jason;
Mutschler, Valentino;
Jenkins, Freya;
Held, Ulrike;
Rushing, Elisabeth Jane;
Wirsching, Hans-Georg;
Weller, Michael;
Regli, Luca;
Neidert, Marian Christoph

Publication type:

Article

Glioblastoma in the oldest old: Clinical characteristics, therapy, and outcome in patients aged 80 years and older.

Published in:

Neuro-Oncology Practice, 2024, v. 11, n. 2, p. 132, doi. 10.1093/nop/npad070

By:

Stadler, Christina;
Gramatzki, Dorothee;
Rhun, Emilie Le;
Hottinger, Andreas F;
Hundsberger, Thomas;
Roelcke, Ulrich;
Läubli, Heinz;
Hofer, Silvia;
Seystahl, Katharina;
Wirsching, Hans-Georg;
Weller, Michael;
Roth, Patrick

Publication type:

Article

The management of lomustine overdose in malignant glioma patients.

Published in:

Neuro-Oncology Practice, 2014, v. 1, n. 4, p. 178, doi. 10.1093/nop/npu023

By:

Wirsching, Hans-Georg;
Tritschler, Isabel;
Palla, Antonella;
Renner, Christoph;
Weller, Michael;
Tabatabai, Ghazaleh

Publication type:

Article

Thymosin β4 induces folding of the developing optic tectum in the chicken ( Gallus domesticus).

Published in:

Journal of Comparative Neurology, 2012, v. 520, n. 8, p. 1650, doi. 10.1002/cne.23004

By:

Wirsching, Hans-Georg;
Kretz, Oliver;
Morosan-Puopolo, Gabriela;
Chernogorova, Petya;
Theiss, Carsten;
Brand-Saberi, Beate

Publication type:

Article

Radiomic Analysis to Predict Outcome in Recurrent Glioblastoma Based on Multi-Center MR Imaging From the Prospective DIRECTOR Trial.

Published in:

Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.636672

By:

Vils, Alex;
Bogowicz, Marta;
Tanadini-Lang, Stephanie;
Vuong, Diem;
Saltybaeva, Natalia;
Kraft, Johannes;
Wirsching, Hans-Georg;
Gramatzki, Dorothee;
Wick, Wolfgang;
Rushing, Elisabeth;
Reifenberger, Guido;
Guckenberger, Matthias;
Weller, Michael;
Andratschke, Nicolaus

Publication type:

Article

Neues zu hirneigenen Tumoren.

Published in:

Therapeutische Umschau, 2018, v. 75, n. 7, p. 438, doi. 10.1024/0040-5930/a001021

By:

Wirsching, Hans-Georg;
Weiler, Michael

Publication type:

Article

m<sup>6</sup>A Regulator Expression Segregates Meningiomas Into Biologically Distinct Subtypes.

Published in:

Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.760892

By:

Chen, Jiawei;
Sun, Shuchen;
Ren, Leihao;
Hua, Lingyang;
Wang, Daijun;
Xie, Qing;
Wirsching, Hans-Georg;
Deng, Jiaojiao;
Weller, Michael;
Gong, Ye

Publication type:

Article

A vasculature-centric approach to developing novel treatment options for glioblastoma.

Published in:

Expert Opinion on Therapeutic Targets, 2021, v. 25, n. 2, p. 87, doi. 10.1080/14728222.2021.1881062

By:

Wirsching, Hans-Georg;
Roth, Patrick;
Weller, Michael

Publication type:

Article

Survival of brain tumour patients with epilepsy.

Published in:

2021

By:

Mastall, Maximilian;
Wolpert, Fabian;
Gramatzki, Dorothee;
Imbach, Lukas;
Becker, Denise;
Schmick, Anton;
Hertler, Caroline;
Roth, Patrick;
Weller, Michael;
Wirsching, Hans-Georg

Publication type:

journal article

Plinabulin, an inhibitor of tubulin polymerization, targets KRAS signaling through disruption of endosomal recycling.

Published in:

Biomedical Reports, 2019, v. 10, n. 4, p. 218

By:

Cimino, Patrick J.;
Huang, Lan;
Du, Lihua;
Wu, Yanping;
Bishop, Jamie;
Dalsing-Hernandez, Jessica;
Kotlarczyk, Kari;
Gonzales, Paul;
Carew, Jennifer;
Nawrocki, Steffan;
Jordan, Mary Ann;
Wilson, Leslie;
Lloyd, G. Kenneth;
Wirsching, Hans-Georg

Publication type:

Article